Starting today, the federal government is accepting public comments regarding the potential rescheduling of marijuana as a schedule 1 controlled substances (which puts it alongside drugs such as heroin).
In response to the United Nations World Health Organization announcing that they will soon review the current international classification of marijuana, the U.S. Food and Drug Administration (FDA) is themselves starting a review, and are asking “interested persons” to submit comments regarding the potential rescheduling of marijuana. The public comment period will be open from today, to April 23.
The FDA is seeking input on the “abuse potential, actual abuse, medical usefulness, trafficking and impact of scheduling changes on availability for medical use of” marijuana and its compounds such as THC and CBD.
Those giving their input can submit up to 5,000 characters and can also attach relevant documents. Commenters have the option of including, or not including their contact information.
Those wanting to submit public comment can do so by clicking here.